The gut microbiome is sensitive to transit time, diet shifts, and overall energy intake reductions that often accompany semaglutide use
Regular medical supervision plays a key role in managing side effects and optimizing weight loss
DAPI mounting medium (SouthernBiotech 0100-20) was used to counterstain the nucleus
FTO and MC4R variants predispose to weight gain and appetite dysregulation, potentially indicating stronger GLP-1 benefit
Based on the plethora of symptoms affecting different organs/systems, PASC-affected population could be categorized into four different clusters or sub-phenotypes: Sub-phenotype-1 (33.8%) with cardiac and renal manifestations, Sub-phenotype-2 (32.8%) with respiratory, sleep and anxiety disorders, Sub-phenotype-3 (23.4%) with skeleton-muscular and nervous disorders, and Sub-phenotype-4 (10.1%) with digestive and pulmonary dysfunctions 123,136